The National Cancer Institute (NCI) is seeking candidates with a medical degree and experience in cancer immunotherapy for the position of Supervisory Physician (GP-602-15), Branch Chief of the Immuno-Oncology Branch (IOB), Developmental Therapeutics Program (DTP), Division of Cancer Treatment and Diagnosis (DCTD).

The candidate will serve as a Supervisory Physician/Branch Chief directing the activities of the IOB (https://dtp.cancer.gov/organization/iob/default.htm) and will collaborate with investigators of the DTP (https://dtp.cancer.gov/).  The candidate will manage and coordinate all functions of the branch including planning, designing and executing preclinical research and clinical development of immunotherapy agents through a cross-functional collaboration within DTP and DCTD. As a senior advisor to the Division Director and Institute Director, the candidate will set priorities for federal investment in the development of new methods, technologies, and treatment paradigms that integrate immunomodulation strategies into clinical studies. The candidate is expected to manage and coordinate a system of grants and contracts to discover, investigate, develop and bring to initial clinical trials novel immuno-oncology products.

 This is a full-time government position. Compensation for this position will be commensurate with the individual’s qualifications and experience as permitted within Federal government appointments. Individuals who apply must be U.S. citizens. The ideal candidate should have a clinical background and training in immunology, medical oncology, hematology, pharmacology, clinical trials, and the development of investigational anti-cancer drugs. To apply to this position, please visit https://www.usajobs.gov.  NCI will be accepting applications to Supervisory Physician recruitment beginning on November 23, 2026.

 Interested candidates should contact Dr. Rosemarie Aurigemma at aurigemr@nih.gov or at (240) 907-9108.

 DHHS, NIH and NCI are Equal Opportunity Employers.